Aurora Cannabis (ACB) Interest & Investment Income (2017 - 2025)
Aurora Cannabis (ACB) reported Interest & Investment Income of $3.4 million for Q4 2025, down 45.99% year-over-year from $6.4 million in Q4 2024, and up 24.31% quarter-over-quarter from $2.8 million in Q3 2025.
Aurora Cannabis (ACB) Interest & Investment Income (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 9 years of Interest & Investment Income data on file, last reported at $3.4 million in Q4 2025.
- Interest & Investment Income for Q4 2025 came in at $3.4 million, down 45.99% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.4 million (down 45.99% YoY), and the FY2023 annual result was $2.5 million, down 29.97% from the prior year.
- Interest & Investment Income improved to $3.4 million in Q4 2025 per ACB's latest filing, from $2.8 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $7.3 million in Q4 2023 and troughed at -$7.2 million in Q1 2022.
- A 5-year average of $2.1 million and a median of $2.5 million in 2023 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2023: Interest & Investment Income sank 913.87% in 2022, then soared 16329.16% in 2023.
- A 5-year view of Interest & Investment Income shows it stood at $2.3 million in 2021, then sank by 101.95% to -$44938.9 in 2022, then soared by 16329.16% to $7.3 million in 2023, then decreased by 12.5% to $6.4 million in 2024, then tumbled by 45.99% to $3.4 million in 2025.
- Business Quant data shows ACB's Interest & Investment Income at $3.4 million in Q4 2025, $2.8 million in Q3 2025, and $1.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 1.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.45 Mn |
| Sep 30, 2025 | 2.77 Mn |
| Jun 30, 2025 | 1.42 Mn |
| Dec 31, 2024 | 6.38 Mn |
| Sep 30, 2024 | 4.63 Mn |
| Jun 30, 2024 | 2.45 Mn |
| Dec 31, 2023 | 7.29 Mn |
| Sep 30, 2023 | 4.92 Mn |
| Jun 30, 2023 | 2.49 Mn |
| Dec 31, 2022 | -44,938.88 |
| Sep 30, 2022 | 3.63 Mn |
| Mar 31, 2022 | -7.15 Mn |
| Dec 31, 2021 | 2.31 Mn |
| Sep 30, 2021 | 358,278.60 |
| Jun 30, 2021 | -1.05 Mn |
| Mar 31, 2021 | -705,558.52 |
| Dec 31, 2020 | -146,507.44 |
| Sep 30, 2020 | -703,146.98 |
| Mar 31, 2020 | 4.00 Mn |
| Dec 31, 2019 | 1.66 Mn |